share_log

ZyVersa Therapeutics | 8-K/A: Current report (Amendment)

SEC announcement ·  Sep 20, 2023 17:15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more